Cited by — Real-world treatment patterns and outcomes of brentuximab vedotin–based therapy in CD30-positive lymphomas in China: the prospective BRAVE study | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Real-world treatment patterns and outcomes of brentuximab vedotin–based therapy in CD30-positive lymphomas in China: the prospective BRAVE study.
No admitted local citation edges point to this work yet.
